menu
    • menu

    Company profile for SAFC

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    SAFC is the custom manufacturing and services business unit of Sigma-Aldrich Corporation. The Company is recognized as a top 10 global specialty chemicals and biologics supplier. As a trusted manufacturer for the life science and high technology industries, SAFC works closely with customers to resolve development challenges and accelerate the product pipeline utilizing its global “Centers of Excellence” and dedicated manuf...
    SAFC is the custom manufacturing and services business unit of Sigma-Aldrich Corporation. The Company is recognized as a top 10 global specialty chemicals and biologics supplier. As a trusted manufacturer for the life science and high technology industries, SAFC works closely with customers to resolve development challenges and accelerate the product pipeline utilizing its global “Centers of Excellence” and dedicated manufacturing facilities. SAFC is committed to being the preferred global supplier of raw materials for development and manufacturing within the life science and high technology industries. We strive to bring our customers relevant solutions and quality products that exceed expectations and grow their business through our customer intimate approach. SAFC endeavors to be at the forefront of helping customers make products that matter and make a difference.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SAFCUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3050 Spruce Street, St. Louis, MO 63103
    Telephone
    Telephone
    +1 314 289 8454
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sigma-aldrich.com/safc.html
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    CPhI India 2024

    CPhI India 2024

    Not Confirmed

    envelop Contact Supplier

    CPhI India 2024

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “LGM Pharma has made significant strides in meeting the evolving needs of its clients”

    “LGM Pharma has made significant strides in meeting the evolving needs of its clients”

    This week, SpeakPharma interviews four senior executives of LGM Pharma — Shailesh Vengurlekar (Senior VP, Quality and Regulatory Affairs), Deepak Thassu (Senior VP, R&D and Regulatory Submission), Selwyn Lustman (Senior VP, Global Sourcing and Procurement), and Mike Stenberg (VP, Business Development). The four VPs talk about expansion in manufacturing capabilities of the Florida-based contract development and manufacturing organization (CDMO), expertise that makes LGM a strong partner and the criteria it adopts while selecting its suppliers.  HIGHLIGHTS// expansion in manufacturing capabilities/ expertise that makes LGM a strong partner/ criteria for selecting its suppliers LGM Pharma recently invested heavily in expanding its CDMO capabilities by 50 percent. Can you share why offering standalone analytical testing services is important to LGM Pharma’s growth strategy? How does it benefit your clients? Vengurlekar: This recent expansion in CDMO capabilities is part of LGM Pharma’s growth strategy that lays importance on diversification. One key area of this diversification is the offering of standalone Analytical Testing Services (ATS). This service plays a crucial role in supporting our clients by providing them with greater flexibility and reliability. LGM Pharma is already a well-established leader in the API supply chain. We have now identified a significant need in the market and are now serving compounding pharmacies, including 503A and 503B facilities. These pharmacies not only require high-quality, GMP-compliant APIs, but also need a trusted, compliant, and capable laboratory to analyze both their APIs and compounded products. Recognizing this opportunity to further support our clients, LGM Pharma has expanded into ATS. We have witnessed tremendous growth since we’ve launched these services. By offering ATS under a separate legal entity — LGM Pharma Solutions — we are able to provide an additional layer of flexibility to our clients. This structure eliminates any conflict of interest. While LGM Pharma LLC handles API supply, LGM Pharma Solutions focuses on delivering top-tier ATS, all under the same LGM Pharma umbrella. This setup enhances trust and allows our clients to work with us more seamlessly. HIGHLIGHTS// diversified into standalone ATS/ well-established leader in API supply chain/ serving compounding pharmacies/ offering APIs and ATS under different legal entities. While suppositories offer clear advantages for certain medications, can you describe how LGM Pharma plans to leverage its expertise in this area to address specific unmet needs in the growing women’s health market? Thassu: We’re taking a dual approach to enhance both our R&D and manufacturing capabilities. First, we’ve introduced a new semi-automatic machine that allows us to produce smaller batches more efficiently. This is particularly important for the suppository segment, where demand doesn’t require large-scale production. The new system enables quicker adjustments to the manufacturing process, providing us with greater flexibility of producing small batches. Second, many of the materials we handle in the women’s health sector are sensitive to heat, light, and oxygen. To address this, we’re upgrading our facility to accommodate these specialized requirements. This ensures we can develop and manufacture products while maintaining the integrity of heat-, light-, and oxygen-sensitive ingredients. Additionally, we’re working closely with clients to prepare for various technical challenges. Whether it’s processing homeopathic ingredients or handling delicate fermentation-based materials, which are highly sensitive to both light and heat, our team has upgraded its skills and equipment to manage these complexities. From technology advancements in manufacturing to specialized handling conditions and improved technical expertise, we’ve made significant strides to ensure we can meet the evolving needs of our clients and their products. HIGHLIGHTS// dual approach to enhance R&D and manufacturing capabilities/ upgrading facilities to accommodate specialized requirements/ working with clients to address challenges. The pandemic underscored supply chain problems. Can you detail the specific criteria LGM Pharma uses while selecting suppliers for its manufacturing processes? Lustman: LGM looks at many facets of a manufacturer before proceeding to approve them for a specific project. We start by checking their regulatory history with the US Food and Drug Administration (FDA) and other authorities. We try to find out if they have received any warning letters. What is their inspection history? Have they received NAIs (no action indicated) and VAIs (voluntary action indicated)? We further investigate the company’s overall business status — we need to know that they are a stable partner to work with in the long term. Manufacturers are then assessed for their overall technology and the number of employees working in various fields, such as R&D, quality control, quality assurance, regulatory affairs, manufacturing, and the educational levels of these employees. Once we have established that the manufacturer is a potential partner, we check their status for a particular project. We look at their advantages, and whether they have a non-infringing route of synthesis (ROS) that will allow early launch. Are they developing a second process that will be more competitive in pricing? And, does the manufacturer have the necessary capacity and/or spare capacity for the project that we are assessing? We need to know whether the drug master file (DMF) has been registered, the current batch size, and the potential for increase in batch size. Pricing is a key indicator — we need to know whether the pricing of the manufacturer is competitive or not, and if the manufacturer will be able to compete in the future as the project matures. LGM always assesses for quality, price, and delivery. Goods must be of the correct quality, at the right price, with delivery time as desired, in order to meet commercial needs. HIGHLIGHTS// investigate various facets of manufacturer before approving them for a project/ look at advantages, non-infringing ROS/ assess for quality, price, delivery Can you highlight specific capabilities and experiences LGM Pharma possesses that make it a strong partner for companies developing antibody-drug-conjugates (ADCs)? Stenberg: ADCs are often peptides linked with small molecules. However, they may also be peptides linked with oligonucleotides. Regardless, LGM can help manage the supply chain associated with the components that are used in the conjugation of the ADC. LGM has extensive experience, and an extensive network around sourcing and managing the supply chain associated with ADC components. LGM’s experience and capabilities extend to sourcing peptides, small molecules or oligonucleotides used in the conjugation process. Additionally, given our deep relationships in the supply chain aspect of this process, LGM may also be able to identify partners who can help with the conjugation process itself. HIGHLIGHTS// extensive experience, network around sourcing, managing supply chain associated with ADC components / identify partners that can help with conjugation process

    Impressions: 466

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients

    #SpeakPharma With LGM Pharma
    09 Nov 2024
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    Medical Breakthroughs in 2024: Alzheimer’s, schizophrenia, COPD, MASH see pathbreaking treatments

    Medical Breakthroughs in 2024: Alzheimer’s, schizophrenia, COPD, MASH see pathbreaking treatments

    This year has seen pivotal advancements in medical innovation. The US Food and Drug Administration (FDA) has approved several groundbreaking therapies that promise to transform patient care across multiple therapeutic areas.Some of the therapies approved have revolutionary delivery mechanisms, while others are first-in-class treatments for previously unaddressed conditions. This week, PharmaCompass brings you a compilation of new pathbreaking approvals of 2024, including advancements in neurology, chronic conditions, mental health conditions, and innovative solutions for various other ailments.Lilly, Alpha Cognition, BMS transform neurological care with new Alzheimer’s, schizophrenia drugsThe neurological treatment landscape saw several major breakthroughs in 2024, particularly in the treatment of Alzheimer’s disease (AD). Eli Lilly’s Kisunla represents a significant advancement in treating early, symptomatic AD. Following decades of failed efforts, Kisunla’s approval, along with that of Eisai-Biogen’s Leqembi last year, marks a turning point in addressing AD.The drug works by targeting and clearing beta amyloid plaque from the brain, thereby attacking the disease’s underlying pathology, rather than just managing symptoms. Administered as an infusion every four weeks, Kisunla’s Medicare coverage makes it accessible to patients in the US who desperately need new treatment options. Alpha Cognition’s Zunveyl emerged as a promising new oral treatment for mild-to-moderate Alzheimer’s-related dementia. Only the second oral AD treatment approved by the FDA in over a decade, Zunveyl is a prodrug, or a biologically inactive compound that can be metabolized by the body to produce a drug. It remains inactive as it passes through the stomach and enhances cholinergic function in the brain.Perhaps one of the most exciting breakthroughs of 2024 was Bristol-Myers Squibb’s Cobenfy. This revolutionary antipsychotic medication for schizophrenia represents the first novel approach to treatment since the 1950s. Unlike traditional antipsychotics that target dopamine receptors, Cobenfy works through cholinergic receptors, offering new hope to patients who struggle with the side effects of conventional treatments.Traditional antipsychotics have been associated with several mild and serious side effects such as weight gain, feeling unmotivated and sluggish, high rates of cardiac disease, and even early death. Cobenfy’s innovative mechanism of action has generated excitement in the medical community. Experts project Cobenfy to bring in US$ 7.5 billion in peak annual sales, thereby validating BMS’ recent, US$ 14-billion acquisition of Karuna Therapeutics.Verona, Sanofi’s drugs revolutionize COPD care; Madrigal’s Rezdiffra offers hope to MASH patients The landscape of chronic obstructive pulmonary disease (COPD) treatment saw remarkable advances in 2024. Verona Pharma’s Ohtuvayre brings the first new mechanism of action in over two decades for COPD treatment. This dual-action, inhaled medication serves as both a bronchodilator and an anti-inflammatory agent, offering a comprehensive approach to symptom management.Adding to this progress, Sanofi and Regeneron’s Dupixent achieved a historic milestone by becoming the first biologic approved for treating COPD. Dupixent is Sanofi’s best-selling drug. It is poised to cross over € 21 billion (US$ 23.5 billion) in sales by 2030, with COPD likely to contribute US$ 2.9 billion, predict analysts. Over 390 million people are living with COPD worldwide.In the field of liver disease, Madrigal Pharmaceuticals’ Rezdiffra became the first FDA-approved treatment for metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver scarring. This approval represents a breakthrough in a field that has been notorious for being a graveyard for failed programs. Rezdiffra offers hope to patients with this common liver condition, which primarily affects those with obesity or type 2 diabetes. The American Liver Foundation has termed this approval a “game-changing” moment in hepatology.For the rare disease community, Ipsen’s Iqirvo emerged as the first new medicine approved in nearly a decade for primary biliary cholangitis (PBC). This first-in-class peroxisome proliferator-activated receptor (PPAR) agonist offers new hope for the approximately 100,000 Americans affected by this condition, particularly women aged 30 to 60 years.A significant breakthrough for patients with hypoparathyroidism came with the approval of Ascendis’ Yorvipath, making it the only treatment for hypoparathyroidism in adults. By directly addressing the underlying hormone deficiency, Yorvipath helps stabilize calcium levels in the blood, reducing the treatment burden associated with managing symptoms through calcium and vitamin D supplements alone.In the realm of pulmonary medicine, Merck’s Winrevair emerged as the first new therapy for pulmonary arterial hypertension (PAH) in over a decade. As the first approved activin-signaling inhibitor therapy, Winrevair represents a novel approach to treating this rare but severe condition that doctors call a “ticking time bomb”. The drug is the first treatment that targets the underlying cause of the lung condition, which typically leads to death within a decade of diagnosis.ARS Pharma launches nasal spray alternative to EpiPen, Eicos introduces med for severe frostbiteLeading the charge in innovative drug delivery is ARS Pharma’s Neffy, the first-ever nasal spray alternative to the EpiPen for treating severe allergic reactions. This groundbreaking advancement represents the first major innovation in anaphylaxis treatment in over a decade. For children and individuals with needle phobia, this nasal spray format addresses one of the most significant barriers to timely treatment of allergic emergencies. Speaking of emergency medicine, Eicos Sciences’ Aurlumyn made history as the first FDA-approved treatment for severe frostbite. This approval fills a critical gap in emergency care, offering a medical intervention that could prevent the need for amputation in severe cases.The cardiovascular space saw its first oral anti-hypertensive therapy that works through a new therapeutic pathway in almost 40 years. Idorsia’s Tryvio is a treatment for hypertension that offers new hope to patients whose blood pressure remains inadequately controlled on existing medications. Idorsia expects millions of patients to benefit from it.Our view This year, the pharmaceutical industry has taken a remarkable leap forward by addressing some of healthcare’s most challenging conditions. Treatments like BMS’ Cobenfy for schizophrenia and Madrigal’s Rezdiffra for MASH demonstrate the industry’s growing ability to translate science into practical therapies. With the growing use of artificial intelligence in the drug industry, we hope that these approvals are just a precursor to a bevy of pathbreaking therapies in the years to come. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 610

    https://www.pharmacompass.com/radio-compass-blog/medical-breakthroughs-in-2024-alzheimer-s-schizophrenia-copd-mash-see-pathbreaking-treatments

    #Phispers by PHARMACOMPASS
    14 Nov 2024
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Merck unveils EU plant cuts and consolidation plan citing Sigma's US strategy
    Merck unveils EU plant cuts and consolidation plan citing Sigma's US strategy

    14 Jul 2017

    // G. MacDonald IN PHARMATECHNOLOGIST

    http://www.in-pharmatechnologist.com/Processing/German-Merck-announces-EU-plant-cuts-and-consolidation-plan

    G. MacDonald IN PHARMATECHNOLOGIST
    14 Jul 2017
    Share Share
    EC says Merck and Sigma-Aldrich broke M&A procedures and could face $170m fine
    EC says Merck and Sigma-Aldrich broke M&A procedures and could face $170m fine

    07 Jul 2017

    // G. MacDonald IN PHARMATECHNOLOGIST

    http://www.in-pharmatechnologist.com/Processing/EC-says-Merck-and-Sigma-Aldrich-broke-M-A-procedures

    G. MacDonald IN PHARMATECHNOLOGIST
    07 Jul 2017
    Share Share
    Improving solubility: MilliporeSigma opens dedicated meglumine site
    Improving solubility: MilliporeSigma opens dedicated meglumine site

    19 Jan 2017

    // Dan Stanton IN PHARMATECHNOLOGIST

    http://www.in-pharmatechnologist.com/Ingredients/Improving-solubility-MilliporeSigma-opens-dedicated-meglumine-site

    Dan Stanton IN PHARMATECHNOLOGIST
    19 Jan 2017
    Share Share
    MilliporeSigma Expands Distribution Agreement with Roche in Canada
    MilliporeSigma Expands Distribution Agreement with Roche in Canada

    01 Dec 2016

    // PR NEWSWIRE

    http://www.prnewswire.com/news-releases/milliporesigma-expands-distribution-agreement-with-roche-in-canada-300367603.html

    PR NEWSWIRE
    01 Dec 2016
    Share Share
    Honeywell Launces New Research Chemicals Business
    Honeywell Launces New Research Chemicals Business

    29 Nov 2016

    // DRUG DEVELOPMENT

    http://www.drug-dev.com/Main/Current-News/Honeywell-Launces-New-Research-Chemicals-Business-1770.aspx

    DRUG DEVELOPMENT
    29 Nov 2016
    Share Share
    Merck's pharma unit faces tougher 2017 as fertility boost recedes
    Merck's pharma unit faces tougher 2017 as fertility boost recedes

    17 Nov 2016

    // Phil Taylor PMLIVE

    http://www.pmlive.com/pharma_news/mercks_pharma_unit_faces_tougher_2017_as_fertility_boost_recedes_1176998

    Phil Taylor PMLIVE
    17 Nov 2016
    Share Share

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    All Excipients

    read-more
    read-more

    01

    Dodecyl Maltoside

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    The Pharmacy Technology
    Not Confirmed
    arrow

    Dodecyl Maltoside

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    The Pharmacy Technology
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 35918

    Submission : 2021-05-25

    Status : Active

    Type : IV

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    N,N-Dimethylacetamide

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    The Pharmacy Technology
    Not Confirmed
    arrow

    N,N-Dimethylacetamide

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    The Pharmacy Technology
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 29898

    Submission : 2015-10-06

    Status : Inactive

    Type : IV

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Rose Bengal

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    The Pharmacy Technology
    Not Confirmed
    arrow

    Rose Bengal

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    The Pharmacy Technology
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 7149

    Submission : 1987-09-14

    Status : Inactive

    Type : IV

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    OLEYLAMINE, PURIFIED (AN EXCIPIENT)

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    The Pharmacy Technology
    Not Confirmed
    arrow

    OLEYLAMINE, PURIFIED (AN EXCIPIENT)

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    The Pharmacy Technology
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 19323

    Submission : 2006-03-28

    Status : Inactive

    Type : IV

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact SAFC and get a quotation

    SAFC is a supplier offers 199 products (APIs, Excipients or Intermediates).

    Find a price of Benzyl Alcohol API bulk with DMF, CEP offered by SAFC

    Find a price of Clomipramine Hydrochloride bulk with DMF, CEP offered by SAFC

    Find a price of Dactinomycin bulk with DMF, JDMF offered by SAFC

    Find a price of Doxylamine Succinate bulk with DMF, CEP offered by SAFC

    Find a price of L-Glutamine bulk with DMF, JDMF offered by SAFC

    Find a price of Sodium Benzoate bulk with DMF, CEP offered by SAFC

    Find a price of L-Glutamine bulk with JDMF offered by SAFC

    Find a price of Sodium Bicarbonate bulk with JDMF offered by SAFC

    Find a price of Aprotinin bulk with CEP offered by SAFC

    Find a price of Bovine Serum bulk with CEP offered by SAFC

    Find a price of Brompheniramine Maleate bulk with DMF offered by SAFC

    Find a price of Catalase bulk with CEP offered by SAFC

    Find a price of Cholic Acid bulk with DMF offered by SAFC

    Find a price of Chymotrypsin bulk with CEP offered by SAFC

    Find a price of Dodecyl Maltoside bulk with DMF offered by SAFC

    Find a price of DPPC bulk with DMF offered by SAFC

    Find a price of Ethanol bulk with DMF offered by SAFC

    Find a price of Glucarpidase bulk with CEP offered by SAFC

    Find a price of Glucose bulk with JDMF offered by SAFC

    Find a price of Glycine bulk with DMF offered by SAFC

    Find a price of Hyaluronidase bulk offered by SAFC

    Find a price of L-Carnosine bulk with CEP offered by SAFC

    Find a price of L-Glutamine bulk with DMF offered by SAFC

    Find a price of L-Tyrosine API bulk with JDMF offered by SAFC

    Find a price of Levothyroxine Sodium bulk with DMF offered by SAFC

    Find a price of Lysine Hydrochloride bulk with DMF offered by SAFC

    Find a price of Maytansinoid DM1 bulk with DMF offered by SAFC

    Find a price of Mebrofenin bulk with DMF offered by SAFC

    Find a price of Nortriptyline bulk with DMF offered by SAFC

    Find a price of Palmitic Acid Chloride bulk with DMF offered by SAFC

    Find a price of Promethazine Hydrochloride bulk with DMF offered by SAFC

    Find a price of Sodium Metaarsenite bulk with DMF offered by SAFC

    Find a price of Sulfo-Smcc bulk with DMF offered by SAFC

    Find a price of Tripalmitin bulk with DMF offered by SAFC

    Find a price of Trypan Blue bulk with DMF offered by SAFC

    Find a price of Urea API bulk with DMF offered by SAFC

    Find a price of Vitamin D bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR60275 bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR60219 bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR60234 bulk with DMF offered by SAFC

    Find a price of EX-CELL PF CHO MEDIUM (MODIFIED) DEFICIENT bulk with DMF offered by SAFC

    Find a price of EX-CELL CD HEK293 VIRAL VECTOR MEDIUM bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR60258 CHOKO PRODUCTION MEDIUM POWDER bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR60274 bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR60229 bulk with DMF offered by SAFC

    Find a price of MAYTANSINOL-N-METHYL-L-ALANYL ESTER bulk with DMF offered by SAFC

    Find a price of EX-CELL PF CHO PART A (MODIFIED) bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR60256 CHOKO FMA POWDER bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR60259, CHOKO STOCK CULTURE MEDIUM POWDER bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM 14366C bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR60273 bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR40118 bulk with DMF offered by SAFC

    Find a price of EX-CELL(TM) 325 PF CHO, SERUM-FREE MEDIUM, PROTEIN FREE bulk with DMF offered by SAFC

    Find a price of QBSF60 MEDIUM PRODUCT NO. 62520 bulk with DMF offered by SAFC

    Find a price of CELL CULTURE MEDIUM CR60257, CHOKO FMB POWDER bulk with DMF offered by SAFC

    Find a price of Medium / medium additive · Sigma EX-CELL PF CHO Mediu m (Modified) bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additives-EX-CELL Advanced (TM) Modified bulk with JDMF offered by SAFC

    Find a price of Medium / medium additive · Ex-CELL EBx GRO-Ⅰ Serum-Fre e Medium for Embryonic Stem Cells bulk with JDMF offered by SAFC

    Find a price of Medium / medium additive · EX-CELL EBx PRO-Ⅰ Serum-Fre e Media bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additives ・ CHO Kit 2 Iron Chelator Solution bulk with JDMF offered by SAFC

    Find a price of Medium / media supplements · EX-CELL (TM) 325 PF CHO Protei n-Free Medium (Modified) bulk with JDMF offered by SAFC

    Find a price of Media/Media Additives GS2-N Low B12 No Hydrocort bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additives ・ CHOKO FMA Powerer bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additives ・ CHOKO FMB Powerer bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additive ・ TE1 bulk with JDMF offered by SAFC

    Find a price of Medium/Medium additives・40X Insect Cell Feed bulk with JDMF offered by SAFC

    Find a price of Medium/medium additive ・R34B Medium bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additive / IMB9 bulk with JDMF offered by SAFC

    Find a price of Medium/Medium additives・EX-CELL(R) Feed Medium bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additive / IMB8 bulk with JDMF offered by SAFC

    Find a price of Medium/Medium additives/GM BI 221 Feed Powder bulk with JDMF offered by SAFC

    Find a price of Medium/medium additive ・Trace Element B Solution B (1000X) bulk with JDMF offered by SAFC

    Find a price of Medium/Medium additives/GM BI 203 Medium Powder bulk with JDMF offered by SAFC

    Find a price of Medium/medium additive R17 bulk with JDMF offered by SAFC

    Find a price of Medium/medium additive ・R36 Low B12 bulk with JDMF offered by SAFC

    Find a price of Medium / medium additive · C8862: EX-CELL CHO DHFR\n- Medium bulk with JDMF offered by SAFC

    Find a price of Medium / medium additive · Fatty Acid Supplement bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additives-EX-CELL Advanced CHO Feed 1 (without glucose) bulk with JDMF offered by SAFC

    Find a price of Medium / medium additive · EX-CELL EBx GRO-Ⅰ Serum-Fre e Media bulk with JDMF offered by SAFC

    Find a price of Medium/medium additive ・F48 Low B12 no HC bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additive ・ CHOKO Production Medium Powerer bulk with JDMF offered by SAFC

    Find a price of Medium / medium additive · StemlineⅡ Hematopoietic Stem C ell Expansion Medium bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additives ・ CHOKO Stock Culture Medium Powerer bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additive / PER2 bulk with JDMF offered by SAFC

    Find a price of Medium/Medium additives・EX-CELL(R) Basal Medium bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additives-SuppAA-1 bulk with JDMF offered by SAFC

    Find a price of Medium/medium additive R7A-1 bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additives-EX-CELL Advanced CHO Feed 1 bulk with JDMF offered by SAFC

    Find a price of Medium/Medium additives/GM BI 215 Medium Powder bulk with JDMF offered by SAFC

    Find a price of Media/Media Additives ・Trace Element E 1000X Solution bulk with JDMF offered by SAFC

    Find a price of Medium/medium additive EX-CELL (R) 293 Serum-Free Medium for HEK 293 Cells bulk with JDMF offered by SAFC

    Find a price of Medium / medium additive · Sigma EX-CELL 302 Serum-Fr ee Medium for CHO Cells bulk with JDMF offered by SAFC

    Find a price of Medium / medium additive · EX-CELL EBx PRO-Ⅰ Serum-Fre e Medium for Embryonic Stem Cells bulk with JDMF offered by SAFC

    Find a price of Medium / medium additive · CHO Feed Bioreactor Supplement bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additives-EX-CELL ACF CHO Medium bulk with JDMF offered by SAFC

    Find a price of Medium / medium additive · EX-CELL 325 PF CHO Serum-Fr ee Medium for CHO Cells bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additives-EX-CELL (TM) CD Hydrolysate Fusion Animal Coordinate Free, Chemically Defined bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additive ・ IMF9-2X bulk with JDMF offered by SAFC

    Find a price of Medium / Medium Additive / IMF8 bulk with JDMF offered by SAFC

    Find a price of Deoxyribonuclease I, Desoxyribonuclease I Crude Lyophilized Powder, Product Number D0876/DN25 and Desoxyribonuclease I Type II, Product Number D4527 bulk with CEP offered by SAFC

    Find a price of 3-5-Diiodothyropropionic Acid bulk offered by SAFC

    Find a price of 3-Amino-3-3-Chlorophenyl-Propanoic Acid bulk offered by SAFC

    Find a price of Ammonium Tetrathiomolybdate bulk offered by SAFC

    Find a price of Armodafinil bulk offered by SAFC

    Find a price of Bovine Insulin bulk offered by SAFC

    Find a price of Bovine Serum bulk offered by SAFC

    Find a price of Calcipotriol bulk offered by SAFC

    Find a price of Calcitriol bulk offered by SAFC

    Find a price of Camptothecine bulk offered by SAFC

    Find a price of Carbamazepine bulk offered by SAFC

    Find a price of Cetyl Alcohol API bulk offered by SAFC

    Find a price of Cholesterol-3,4-13C2 bulk offered by SAFC

    Find a price of Copper bulk offered by SAFC

    Find a price of Cortisol-9,11,12,12-D4 bulk offered by SAFC

    Find a price of Dextrans bulk offered by SAFC

    Find a price of Fenbendazole bulk offered by SAFC

    Find a price of Galactomannan bulk offered by SAFC

    Find a price of Gentisic Acid bulk offered by SAFC

    Find a price of GUANIDINE HYDROCHLORIDE API bulk offered by SAFC

    Find a price of Halobetasol bulk offered by SAFC

    Find a price of Halofuginone Lactate bulk offered by SAFC

    Find a price of Hexadimethrine Bromide bulk offered by SAFC

    Find a price of Homotaurine bulk offered by SAFC

    Find a price of Hydroxydopamine Hydrobromide bulk offered by SAFC

    Find a price of Iron bulk offered by SAFC

    Find a price of Isobutylmethylxanthine bulk offered by SAFC

    Find a price of Isobutyramide bulk offered by SAFC

    Find a price of Isosulfan Blue bulk offered by SAFC

    Find a price of L-Carnosine bulk offered by SAFC

    Find a price of L-Glutamine bulk offered by SAFC

    Find a price of Mafodotin [Usan] bulk offered by SAFC

    Find a price of Mebrofenin bulk offered by SAFC

    Find a price of Mechlorethamine bulk offered by SAFC

    Find a price of Methacetin-13C bulk offered by SAFC

    Find a price of Methyl Tert-Butyl Ether bulk offered by SAFC

    Find a price of Methylformamide bulk offered by SAFC

    Find a price of Pefcalcitol bulk offered by SAFC

    Find a price of Penicillamine bulk offered by SAFC

    Find a price of Pentamidine Isethionate bulk offered by SAFC

    Find a price of Percorten bulk offered by SAFC

    Find a price of Polygalacturonic Acid bulk offered by SAFC

    Find a price of Putrescine Hydrochloride bulk offered by SAFC

    Find a price of Rhodamine 123 bulk offered by SAFC

    Find a price of Sodium Bicarbonate bulk offered by SAFC

    Find a price of Sodium Butyrate bulk offered by SAFC

    Find a price of Sodium Metaarsenite bulk offered by SAFC

    Find a price of Sodium Octanoate-1-13C bulk offered by SAFC

    Find a price of Squalene API bulk offered by SAFC

    Find a price of Thrombin bulk offered by SAFC

    Find a price of Trypan Blue bulk offered by SAFC

    Find a price of Vitamin D3 bulk offered by SAFC

    Find a price of CHO MEDIUM-ANIMAL COMPONENT-FREE bulk offered by SAFC

    Find a price of EX-CELL 302 MEDIUM (MODIFIED) CAT. #62630 bulk offered by SAFC

    Find a price of EX-CELL PF CHO MEDIUM (MODIFIED) CATALOG NO. 67480 bulk offered by SAFC

    Find a price of EX-CELL PF CHO MEDUIM (MODIFIED), CATALOG NO. 62625 bulk offered by SAFC

    Find a price of 1(2PHENYLETHYL)4(N(2PYRAZYL)2(FUROYLAMIDO)PIPERIDINE HCl bulk offered by SAFC

    Find a price of EX-CELL PF CHO MEDIUM (MODIFIED) DEFINED SERUM-FREE MEDIUM bulk offered by SAFC

    Find a price of EX-CELL CD HYDROLYSATE FUSION, ANIMAL COMPONENT FREE, CHEMICALLY-DEFINED LIQUID MEDIA, (PRODUCT NO. 14700C), DRY POWDER MEDIA (PRODUCT NO. 24700C) bulk offered by SAFC

    Find a price of EX-CELL PF CHO bulk offered by SAFC

    Find a price of PHOSPHATE BUFFERED SALINE (PRODUCT 62137) bulk offered by SAFC

    Find a price of STEMLINE(TM) DENDRITIC CELL MATURATION MEDIUM bulk offered by SAFC

    Find a price of CHO MEDIUM MODIFICATION 21 bulk offered by SAFC

    Find a price of EX-CELL 400 bulk offered by SAFC

    Find a price of EX-CELL (TM) 293 MEDIUM bulk offered by SAFC

    Find a price of BIOTAIN-MPS TM CONCENTRATE (100X) bulk offered by SAFC

    Find a price of EX-CELL(TM) 302, MEDIUM, SERUM-FREE MEDIUM bulk offered by SAFC

    Find a price of EX-CELL(TM) 302, CHO, SERUM-FREE MEDIUM bulk offered by SAFC

    Find a price of EX-CELL (TM) VPRO bulk offered by SAFC

    Find a price of ROSE BENGAL, DISODIUM SALT, SIGMA-ALDRICH CHEMICAL CO. PRODUCT NUMBER W184-3 bulk offered by SAFC

    Find a price of EX-CELL 302 MEDIUM (GS MODIFIED), CATALOG NO. 62639 bulk offered by SAFC

    Find a price of 2-METHOXYESTRA-3,17 B-DIOL bulk offered by SAFC

    Find a price of 9-AMINO-1,2,3,4,-TETRAHYDROCRIDINE HCL. (THA) bulk offered by SAFC

    Find a price of EX-CELL PF CHO MEDIUM(MODIFIED) bulk offered by SAFC

    Find a price of EX-CELL 301 COMPLETE MEDIUM (MODIFIED) bulk offered by SAFC

    Find a price of SGD-1006 (SG6) bulk offered by SAFC

    Find a price of 62180 bulk offered by SAFC

    Find a price of HEMOCYANIN FROM KEYHOLE LIMPET bulk offered by SAFC

    Find a price of STEMLINE NEURAL STEM CELL EXPANSION MEDIUM bulk offered by SAFC

    Find a price of EX-CELL 301 bulk offered by SAFC

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN WISCONSIN. bulk offered by SAFC

    Find a price of 93% DME (HG)/5% NCTC (CAT. NO. 52-589) bulk offered by SAFC

    Find a price of EX-CELL(TM) 302, CHO, SERUM-FREE MEDIUM(MODIFIED) bulk offered by SAFC

    Find a price of CHO ANIMAL-FREE MEDIUM MODIFICATION 21 bulk offered by SAFC

    Find a price of EX-CELL(TM) 325 PF CHO PROTEIN-FREE MEDIUM (MODIFIED) bulk offered by SAFC

    Find a price of STEMMAX(TM), PRODUCT NO. 62647 bulk offered by SAFC

    Find a price of PF-11 bulk offered by SAFC

    Find a price of EX-CELL 610 HSF HYBRIDOMA, SERUM-FREE MEDUIM. CATALOG NO. 14610 bulk offered by SAFC

    Find a price of Q1196-9 bulk offered by SAFC

    Find a price of EX-CELL 325 PF CHO PROTEIN FREE MEDIUM bulk offered by SAFC

    Find a price of EX-CELLr ANTIFOAM GAMMA IRRADIATED BY SER-TAINr PROCESS bulk offered by SAFC

    Find a price of EX-CELL 525 FOR PER C6 CELLS, DEFINED SERUM FREE MEDIUM bulk offered by SAFC

    Find a price of PEG TELOMER B bulk offered by SAFC

    Find a price of EX-CELL 325 PF CHO (MODIFIED) PRODUCT NO. 63131 bulk offered by SAFC

    Find a price of 67210 bulk offered by SAFC

    Find a price of STEMLINE™ MESENCHYMAL STEM CELL EXPANSION MEDIUM bulk offered by SAFC

    Find a price of SERUM-FREE MEDIA SUPPLEMENT PART A (100 X) bulk offered by SAFC

    Find a price of ISCOVE'S MODIFIED DULBECCO'S MEDIUM (IMDM) bulk offered by SAFC

    Find a price of DMS-12 (100X) CONCENTRATE bulk offered by SAFC

    Find a price of STEMLINE(TM) II HEMATOPOIETIC STEM CELL EXPANSION MEDIUM bulk offered by SAFC

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search